Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population  Edmund S. Kassis, MD, Ara A. Vaporciyan,

Slides:



Advertisements
Similar presentations
The evolution of treatment outcomes for resected stage IIIA non–small cell lung cancer over 16 years at a single institution  Linda W. Martin, MD, Arlene.
Advertisements

Manuel J. Antunes, MD, PhD, DSc 
Stephen R. Broderick, MD, MPHS 
Two decades of pediatric lung transplant in the United States: Have we improved?  Farhan Zafar, MD, Jeffrey S. Heinle, MD, Marc G. Schecter, MD, Joseph.
Liver Metastasis Is Associated with Poor Progression-Free Survival in Patients with Non–Small Cell Lung Cancer Treated with Nivolumab  Tomoko Funazo,
The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.
One in every 14 patients with early-stage lung cancer is not being treated!  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular Surgery 
It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible  Alessandro Brunelli,
Utility of PET, CT, and EUS to Identify Pathologic Responders in Esophageal Cancer  Stephen G. Swisher, MD, Mary Maish, MD, Jeremy J. Erasmus, MD, Arlene.
Neoadjuvant chemoradiotherapy followed by surgery for esophageal adenocarcinoma: Significance of microscopically positive circumferential radial margins 
Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis
Lung cancer screening: No more excuses
Paul J. Scheel, BS, Traves D. Crabtree, MD, Jennifer M
Puja Gaur, MD, Wayne L. Hofstetter, MD, B
Histopathologic Response Criteria Predict Survival of Patients with Resected Lung Cancer After Neoadjuvant Chemotherapy  Apar Pataer, MD, PhD, Neda Kalhor,
Ground glass opacity of the lung: The veil that needs lifting
Non-Small Cell Lung Cancer Resection in Lymphoma Patients
Intrinsic cardiac stem cells are essential for regeneration
Computed Tomography Findings Predicting Invasiveness of Thymoma
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Abracadabra I, II…HeartMate 3?
David C. Rice, MB, BCh, Matthew A
Victor van Berkel, MD, PhD 
Anthony J. Ascioti, MD, Wayne L. Hofstetter, MD, Michael J
Liver Metastasis Is Associated with Poor Progression-Free Survival in Patients with Non–Small Cell Lung Cancer Treated with Nivolumab  Tomoko Funazo,
Proposed Modification of Nodal Status in AJCC Esophageal Cancer Staging System  Wayne Hofstetter, MD, Arlene M. Correa, PhD, Neby Bekele, PhD, Jaffer A.
The Role of Consolidation Therapy for Stage III Non-Small Cell Lung Cancer With Persistent N2 Disease After Induction Chemotherapy  Arya Amini, BA, Arlene.
The lord of the rings  Antonio Miceli, MD, PhD 
Dhakshina Moorthy Ganeshan, MD, Arlene M
The Applicability of the Proposed IASLC Staging Revisions to Small Cell Lung Cancer (SCLC) with Comparison to the Current UICC 6th TNM Edition  Sai-Hong.
Treatment trends in early-stage lung cancer in the United States, 2004 to 2013: A time- trend analysis of the National Cancer Data Base  Kathryn E. Engelhardt,
Outcomes After Extrapleural Pneumonectomy and Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma  David C. Rice, MB, BCh, Craig.
The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery  Vinay Badhwar, MD  The Journal of Thoracic and.
It's not “just a shunt” but sometimes it should be…
Prolonged survival in patients with resected non–small cell lung cancer and single-level N2 disease  Steven M Keller, MD, Mark G Vangel, PhD, Henry Wagner,
A first start for lung transplantation?
Commentary: Tag, you're it
Stephen R. Broderick, MD, MPHS 
Get it right the first time
Journal of Thoracic Oncology
Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow?  Jules Lin, MD  The Journal of Thoracic and Cardiovascular.
Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD 
Frozen elephant trunk technique: Ready to get back to the future?
Attachment disorder in thoracoabdominal surgery
Video-assisted resection for lung cancer results in fewer complications  Lunxu Liu, PhD, MD, FRCS  The Journal of Thoracic and Cardiovascular Surgery 
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
David C. Rice, MB, BCh, Jeremy J. Erasmus, MD, Craig W
Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer  Stephen G. Swisher, MDa, Linda DeFord, MSb, Kelly.
3p22.1 and 10q22.3 Deletions Detected by Fluorescence In Situ Hybridization (FISH): A Potential New Tool for Early Detection of Non-small Cell Lung Cancer.
Visceral Pleural Invasion Is Not Predictive of Survival in Patients With Lung Cancer and Smaller Tumor Size  Elizabeth David, MD, Peter F. Thall, PhD,
Predictors of Recurrent Pulmonary Metastases and Survival After Pulmonary Metastasectomy for Colorectal Cancer  Shanda H. Blackmon, MD, MPH, Elizabeth.
Development of a patient-centered aggregate score to predict survival after lung resection for non–small cell lung cancer  Alessandro Brunelli, MD, Michele.
Mara B. Antonoff, MD, Wayne L. Hofstetter, MD, Arlene M
Syphilitic aortitis: The bigger picture
The origins of open heart surgery at the University of Minnesota 1951 to 1956  Richard A. DeWall, MD  The Journal of Thoracic and Cardiovascular Surgery 
Bryan M. Burt, MD  The Journal of Thoracic and Cardiovascular Surgery 
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
The future of cardiac surgery training: A survival guide
Ralph E. Delius, MD  The Journal of Thoracic and Cardiovascular Surgery 
The Robin Hood principle in the treatment of congenital heart disease: Taking technologic developments intended for adults and using it in kids  Paul.
“The more things change…”: The challenges ahead
Aritoshi Hattori, MD, Kenji Suzuki, MD 
Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter  Joe B Putnam, MD, Garrett L Walsh, MD, Stephen G Swisher,
Apples remain apples NO matter what
Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery  Raja M. Flores, MD  The Journal.
Samuel Kim, MD  The Journal of Thoracic and Cardiovascular Surgery 
Improved Long-Term Outcome With Chemoradiotherapy Strategies in Esophageal Cancer  Stephen G. Swisher, MD, Wayne Hofstetter, MD, Ritsuko Komaki, MD, Arlene.
Jenifer L. Marks, MD, Wayne Hofstetter, MD, Arlene M
The risk of second primary tumors after resection of stage I nonsmall cell lung cancer  David Rice, MB, BCh, Hyung-Woo Kim, MS, Anita Sabichi, MD, Scott.
Presentation transcript:

Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population  Edmund S. Kassis, MD, Ara A. Vaporciyan, MD, Stephen G. Swisher, MD, Arlene M. Correa, PhD, B. Nebiyou Bekele, PhD, Jeremy J. Erasmus, MD, Wayne L. Hofstetter, MD, Ritsuko Komaki, Reza J. Mehran, Cesar A. Moran, Katherine M. Pisters, David C. Rice, MD, Garrett L. Walsh, MD, Jack A. Roth, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 138, Issue 2, Pages 412-418.e2 (August 2009) DOI: 10.1016/j.jtcvs.2009.01.033 Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Kaplan–Meier survival by overall stage for UICC-6 (A) and IASLC (B). HR, Hazard ratio; CI, confidence interval; MS, median survival; NR, not reached. UICC, Union Internationale Contre le Cancer; IASLC, International Association for the Study of Lung Cancer. The Journal of Thoracic and Cardiovascular Surgery 2009 138, 412-418.e2DOI: (10.1016/j.jtcvs.2009.01.033) Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Shifting of stage after application of IASLC system. IASLC, International Association for the Study of Lung Cancer. The Journal of Thoracic and Cardiovascular Surgery 2009 138, 412-418.e2DOI: (10.1016/j.jtcvs.2009.01.033) Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions

Appendix Figure 1 Distribution of differences under the null distribution. The Journal of Thoracic and Cardiovascular Surgery 2009 138, 412-418.e2DOI: (10.1016/j.jtcvs.2009.01.033) Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions